Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1013 | 1116 | 917 | 925 | 2066 | - |
Fund Return | 1.32% | 11.61% | -8.27% | -2.56% | 15.62% | - |
Place in category | 216 | 502 | 67 | 29 | 16 | - |
% in Category | 37 | 82 | 14 | 9 | 7 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fullgoal Tianhui Selected Growth Mi | 27.72B | 4.40 | -11.62 | 12.67 | ||
Fullgoal CSI 300 Strengthen Fund | 11.41B | 6.02 | -7.99 | 10.45 | ||
Fullgoal Tianding China Securities | 10.04B | 10.00 | 6.99 | 13.52 | ||
Fullgoal China Secs new energy veh | 7.58B | -6.11 | -11.57 | - | ||
Fullgoal China Securities 500 Index | 6.84B | 2.78 | -1.86 | 9.81 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 12.25B | 7.83 | -9.69 | - | ||
TianHong ChiNext Index A | 6.81B | -1.11 | -14.35 | - | ||
TianHong ChiNext Index C | 6.81B | -1.19 | -14.52 | - | ||
ICBC Credit Literary Ids Eq | 5.51B | 6.59 | -8.76 | - | ||
Harvest Emerging Industry Eq | 5.46B | -2.33 | -17.92 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meinian Onehealth Healthcare | CNE000001LV7 | 7.94 | 4.62 | +0.44% | |
China National Nuclear Power | CNE1000022N7 | 5.46 | 9.19 | +1.55% | |
Zhejiang Shouxiangu Pharma | CNE100002XJ4 | 5.37 | 28.00 | -0.89% | |
Shandong Hualu Hengsheng | CNE000001BM7 | 5.13 | 29.38 | 0.00% | |
Science City A | CNE0000012L4 | 4.93 | 19.08 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review